ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JEFFREY GEORGE M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,405Medicare Part D Prescriptions Filled, Including Refills

Rank: 611 out of 4623

$508K Total Retail Price of All Prescriptions

Rank: 712 out of 4623

542 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

19% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 7,743 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 450 280 S3 1 3
LEVOTHYROXINE SODIUM 433 361 2 1
SIMVASTATIN 361 350 3 2
LISINOPRIL 360 328 4 4
AMLODIPINE BESYLATE 330 301 5 5
OMEPRAZOLE 196 184 6 7
ZOLPIDEM TARTRATE 164 149 7 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 135 8 19
TAMSULOSIN HCL 148 134 9 29
LOSARTAN POTASSIUM 144 121 10 21
TRAZODONE HCL 142 81 11 42
CITALOPRAM HBR 137 107 12 23
FUROSEMIDE 135 104 13 8
METFORMIN HCL 134 122 14 6
PRAVASTATIN SODIUM 132 121 15 11
HYDROCHLOROTHIAZIDE 132 110 15 10
GABAPENTIN 130 91 17 16
METOPROLOL TARTRATE 127 102 18 9
CARVEDILOL 117 96 19 25
TRAMADOL HCL 108 79 20 15
MELOXICAM 108 83 20 27
PANTOPRAZOLE SODIUM 108 84 20 35
METFORMIN HCL ER 105 101 23 51
POTASSIUM CHLORIDE 105 66 23 14
WARFARIN SODIUM 102 91 25 24
METOPROLOL SUCCINATE 101 98 26 13
SERTRALINE HCL 99 97 27 26
FLUTICASONE PROPIONATE 94 78 28 32
ATORVASTATIN CALCIUM 88 76 29 12
CYCLOBENZAPRINE HCL 84 45 R 30 53
LOVASTATIN 82 74 31 34
NEXIUM 78 46 32 17
NAMENDA 78 71 32 36
CRESTOR 75 57 34 20
BENAZEPRIL HCL 73 65 35 70
FENOFIBRATE 69 50 36 54
DIOVAN 63 51 37 39
AMITRIPTYLINE HCL 63 56 R 37 69
VENLAFAXINE HCL ER 60 34 39 132
LOSARTAN-HYDROCHLOROTHIAZIDE 59 59 40 46
GLIPIZIDE ER 58 55 41 86
NIFEDIPINE ER 57 48 42 97
DONEPEZIL HCL 56 56 43 30
ROPINIROLE HCL 56 43 43 108
TRIAMTERENE-HCTZ 56 56 43 80
ATENOLOL 56 56 43 28
ESTRADIOL 55 40 R 47 130
SYNTHROID 55 55 47 73
SPIRONOLACTONE 53 46 49 77
AZITHROMYCIN 51 46 50 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.